v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (8,407) $ (5,813)
Adjustment to reconcile net loss to net cash used in operating activities:    
Non-cash stock-based compensation 798 505
Non-cash lease expense 153 147
Changes in operating assets and liabilities:    
Prepaid expenses and other assets (652) (1,132)
Accounts payable 685 277
Accrued expenses and other current liabilities (1,264) (2,895)
Operating lease liabilities (159) (159)
Net cash used in operating activities (8,846) (9,070)
Cash flows from financing activities:    
Proceeds from the exercise of common stock warrants 44,084 503
Proceeds from issuance of common stock, common stock warrants, and pre-funded warrants, net of issuance costs 0 23,030
Proceeds from employee stock purchases 66 48
Net cash provided by financing activities 44,150 23,581
Net increase in cash, cash equivalents, restricted cash, and restricted cash equivalents 35,304 14,511
Cash, cash equivalents, restricted cash, and restricted cash equivalents at the beginning of period 71,893 13,986
Cash, cash equivalents, restricted cash, and restricted cash equivalents at the end of period 107,197 28,497
Supplemental disclosure of cash flow information:    
Cash received during the period for interest 845 250
Supplemental disclosure of non-cash investing and financing activities:    
Offering expenses included in accounts payable and accrued expenses and other current liabilities $ 0 $ 21